The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Despite there being a valid 'cspec' property in the messages there's a discrepancy in message contents and CSPEC data: * Message Gene: DYSF CSPEC Genes: [ 'CAPN3' ] * Message MONDOs: MONDO:0015152 CSPEC MONDO: [ 'MONDO:0015152' ]
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000070.2(CAPN3):c.223dup

CA220346

92411 (ClinVar)

Gene: DYSF
Condition: autosomal recessive limb-girdle muscular dystrophy
Inheritance Mode: Autosomal recessive inheritance
UUID: 87928b1c-f1fb-4823-bed7-a7d20c0f6cf4
Approved on: 2025-01-07
Published on: 2025-01-07

HGVS expressions

NM_000070.2(CAPN3):c.223dup
NC_000015.10:g.42360028dup
CM000677.2:g.42360028dup
NC_000015.9:g.42652226dup
CM000677.1:g.42652226dup
NC_000015.8:g.40439518dup
NG_008660.1:g.16926dup
ENST00000349748.8:c.223dup
ENST00000357568.8:c.223dup
ENST00000397163.8:c.223dup
ENST00000466369.5:n.540+5575dup
ENST00000483208.5:n.540+5575dup
ENST00000495723.1:n.540+5575dup
ENST00000549793.5:n.540+5575dup
ENST00000318023.11:c.223dup
ENST00000349748.7:c.223dup
ENST00000357568.7:c.223dup
ENST00000397163.7:c.223dup
NM_000070.2:c.223dup
NM_024344.1:c.223dup
NM_173087.1:c.223dup
NM_000070.3:c.223dup
NM_024344.2:c.223dup
NM_173087.2:c.223dup
More

Pathogenic

Met criteria codes 4
PM3_Supporting PM2_Supporting PVS1 PP4
Not Met criteria codes 19
BS3 BS1 BS2 BP5 BP7 BP3 BP4 BP1 BA1 PM1 PM4 PM5 PS4 PS2 PS3 PS1 PM6 PP3 PP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CAPN3 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_000070.3: c.223dup p.(Tyr75LeufsTer5) variant in CAPN3 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 1/24, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been detected in at least four individuals with LGMD (PMID: 27854218, 30564623; LOVD CAPN3_000537). In at least one case, the variant was identified in unknown phase with a pathogenic variant (c.2362_2363delinsTCATCT p.(Arg788fsTer14), 0.5 pts, LOVD Individual #00220184) (PM3_Supporting), and at least one patient with this variant displayed progressive limb girdle muscle weakness (PP4). This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/07/2025): PVS1, PM3_Supporting, PP4, PM2_Supporting.
Met criteria codes
PM3_Supporting
This variant has been detected in at least four individuals with LGMD (PMID: 27854218, 30564623; LOVD CAPN3_000537). In at least one case, the variant was identified in unknown phase with a pathogenic variant (c.2362_2363delinsTCATCT p.(Arg788fsTer14), 0.5 pts) (PM3_Supporting).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_Supporting).
PVS1
The c.223dup p.(Tyr75LeufsTer5) variant in CAPN3 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 1/24 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PP4
At least one patient with this variant displayed progressive limb girdle muscle weakness (PP4).
Not Met criteria codes
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.